Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Manuel Litchman
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:CAR-T_therapies
gene therapies for rare diseases |
| gptkbp:focusesOn |
oncology
gene therapy |
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:Worcester,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mustang Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:parentCompany |
gptkb:Fortress_Biotech
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
MBIO
|
| gptkbp:website |
https://www.mustangbio.com/
|
| gptkbp:bfsParent |
gptkb:Fortress_Biotech
|
| gptkbp:bfsLayer |
7
|